Penumbra Inc. (PEN)
265.75
-3.87 (-1.44%)
At close: Mar 28, 2025, 10:42 AM
Penumbra Inc. Revenue Breakdown
| Quarter | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuro Revenue | 171.41M | 108.81M | 98.55M | 90.32M | 84.8M | 81.09M | 84.65M | 83.57M | 80.04M | 75.92M | 58.84M | 78.08M | 85.42M | 329.51M | 244.56M | 81.47M | 74.69M | 74.2M | 71.43M | 182.2M | 50.25M | 51.35M | 47.53M | 45.36M | 41.28M | 105.1M | 36.31M |
| Neuro Revenue Growth | +57.52% | +10.42% | +9.11% | +6.50% | +4.58% | -4.21% | +1.29% | +4.42% | +5.43% | +29.03% | -24.64% | -8.60% | -74.08% | +34.73% | +200.19% | +9.08% | +0.66% | +3.87% | -60.79% | +262.59% | -2.15% | +8.03% | +4.79% | +9.88% | -60.72% | +189.46% | n/a |
| Peripheral Vascular Revenue | 99.54M | 152.68M | 142.85M | 123.36M | 123.54M | 122.81M | 105.47M | 100.68M | 89.17M | 75.16M | 46.27M | 59.25M | 59.84M | 212.13M | 152.28M | 46.97M | 37.12M | 35.44M | 31.27M | 78.35M | 22.96M | 21.75M | 19.65M | 19.74M | 16.64M | 30.58M | 14.11M |
| Peripheral Vascular Revenue Growth | -34.81% | +6.88% | +15.80% | -0.15% | +0.60% | +16.45% | +4.75% | +12.92% | +18.64% | +62.43% | -21.91% | -0.99% | -71.79% | +39.31% | +224.21% | +26.54% | +4.73% | +13.35% | -60.09% | +241.20% | +5.57% | +10.68% | -0.46% | +18.69% | -45.60% | +116.76% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 301.37M | 255.42M | 219.8M | 160.14M | 355.22M | 290.72M | 219.17M | 176.1M | 127.31M |
| Non-Us Revenue Growth | +17.99% | +16.20% | +37.25% | -54.92% | +22.19% | +32.64% | +24.46% | +38.33% | n/a |
| United States Revenue | 757.15M | 591.72M | 527.79M | 400.27M | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +27.96% | +12.11% | +31.86% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 147.94M | 139.74M | 139.42M | 141.93M | 130.02M | 125.92M | 127.44M | 123.08M | 115.63M | 108.57M | 114.61M | 110.9M | 113.5M | 94.4M | 90.64M | 79.8M | 76.6M | 76.16M | 59.85M | 74.45M | 74.69M | 69.29M | 67.67M | 61.09M | 61.18M | 55.93M | 54.78M | 54.5M | 51.47M | 45.96M | 44.16M | 42.72M | 41.62M | 37.74M | 35.88M | 33.07M | 29.15M | 26.75M | 26.4M | 19.55M |
| Selling, General, and Administrative Revenue Growth | +5.87% | +0.23% | -1.77% | +9.16% | +3.26% | -1.19% | +3.54% | +6.44% | +6.50% | -5.27% | +3.35% | -2.29% | +20.24% | +4.15% | +13.58% | +4.17% | +0.58% | +27.24% | -19.61% | -0.31% | +7.79% | +2.40% | +10.76% | -0.14% | +9.37% | +2.11% | +0.51% | +5.88% | +11.98% | +4.07% | +3.38% | +2.65% | +10.28% | +5.20% | +8.49% | +13.43% | +8.97% | +1.36% | +35.04% | n/a |
| Research and Development Revenue | 20.01M | 25.2M | 24.94M | 24.63M | 21.94M | 20.96M | 21.54M | 19.99M | 17.96M | 21.32M | 19.56M | 20.56M | 52M | 16.73M | 17.74M | 18.08M | 19.45M | 34.92M | 22.73M | 12.95M | 12.86M | 13.73M | 13.46M | 11.67M | 10.87M | 9.09M | 8.19M | 8.01M | 8.4M | 8.13M | 8.09M | 7.03M | 6.11M | 6.5M | 6.26M | 5M | 5.48M | 4.56M | 4.79M | 3.19M |
| Research and Development Revenue Growth | -20.61% | +1.05% | +1.28% | +12.23% | +4.70% | -2.69% | +7.76% | +11.26% | -15.74% | +9.00% | -4.89% | -60.46% | +210.77% | -5.66% | -1.87% | -7.09% | -44.29% | +53.68% | +75.54% | +0.66% | -6.35% | +2.01% | +15.39% | +7.36% | +19.52% | +10.97% | +2.25% | -4.62% | +3.31% | +0.47% | +15.07% | +15.07% | -5.91% | +3.72% | +25.25% | -8.81% | +20.26% | -4.84% | +50.17% | n/a |